Radioactivity Retention of Liquid Iodine-131 in Residual Syringes: Implications for Radiation Exposure and Radioactive Waste Management in Radiopharmaceutical Preparation
DOI:
https://doi.org/10.59141/-.v8i2.561Keywords:
iodine-131, radiopharmaceutical preparation, residual syringe activity, radioactivity retention, radiation exposureAbstract
Residual radioactivity in syringes used during the preparation of liquid iodine-131 radiopharmaceuticals may contribute to avoidable radiation exposure and increase the radioactive waste burden. Although radioactivity retention in syringes has been reported for several radiopharmaceutical preparations, safety-oriented evaluations of residual iodine-131 activity in liquid formulations remain limited. This study aimed to investigate the relationship between residual radioactivity retention and radiation exposure rates in syringes following liquid iodine-131 preparation and to assess the implications for radioactive waste management. This experimental study used sodium iodide labeled with iodine-131 (Na¹³¹I) in liquid form. Initial and residual syringe activities were measured using a radionuclide dose calibrator, while ambient dose equivalent rates were measured using a gamma radiation survey meter. Residual activity, percentage radioactivity retention, radiation dose rate, and estimated decay-in-storage duration were analyzed descriptively. Pearson's correlation analysis and simple linear regression were performed to evaluate the relationship between radioactivity retention and measured radiation dose rates. Sequential rinsing with water for injection and 0.9% sodium chloride solution was evaluated as an approach to reducing residual radioactivity. Mean residual syringe activity increased from 0.270 ± 0.012 mCi at an initial activity concentration of 5 mCi/mL to 0.435 ± 0.016 mCi at 15 mCi/mL. Radioactivity retention increased from 12.90 ± 0.63% to 20.97 ± 0.74%, accompanied by an increase in the measured radiation dose rate from 2.703 ± 0.102 to 4.131 ± 0.237 µSv/h. Radioactivity retention exhibited a strong positive correlation with the radiation dose rate (Pearson's r = 0.9412, R² = 0.8858, p < 0.0001). Sequential rinsing reduced the measured dose rate from 4.160 ± 0.186 to 1.329 ± 0.034 µSv/h using water for injection and from 4.190 ± 0.117 to 1.314 ± 0.023 µSv/h using 0.9% sodium chloride solution. These findings demonstrate a strong association between residual syringe radioactivity and measured radiation dose rates following liquid iodine-131 preparation, highlighting the contribution of residual activity to the initial radioactive waste burden. Controlled rinsing procedures may help reduce residual syringe activity and support radiation protection, contamination control, and radioactive waste management practices in nuclear medicine facilities.
Downloads
References
Barbosa, N., Sandoval Castillo, L., & Quimbayo, J. S. (2022). Discharges of Nuclear Medicine Radioisotopes: The Impact of an Abatement System. Health Physics, 122(5), 586–593. https://doi.org/10.1097/HP.0000000000001543
Bergeron, D. E., & Cessna, J. T. (2018). An update on “dose calibrator” settings for nuclides used in nuclear medicine. Nuclear Medicine Communications, 39(6), 500–504. https://doi.org/10.1097/MNM.0000000000000833
Bly, R. (2023). Radiation safety of current European practices of therapeutic nuclear medicine: survey results from 20 HERCA countries. Journal of Radiological Protection, 43(1). https://doi.org/10.1088/1361-6498/acafef
Galbraith, W., Chen, X., Talley, K., & Grantham, V. (2015). Assessment of 99mTc-succimer residual activity using inert nonreactive syringes. Journal of Nuclear Medicine Technology, 43(1), 61–63. https://doi.org/10.2967/jnmt.114.147983
Gillings, N., Hjelstuen, O., Ballinger, J., Behe, M., Decristoforo, C., Elsinga, P., Ferrari, V., Peitl, P. K., Koziorowski, J., Laverman, P., Mindt, T. L., Neels, O., Ocak, M., Patt, M., & Todde, S. (2021). Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals. EJNMMI Radiopharmacy and Chemistry, 6(1), 8. https://doi.org/10.1186/s41181-021-00123-2
Gunasekera, R. D., Notghi, A., Mostafa, A. B., & Harding, L. K. (2001). Adsorption of radiopharmaceuticals to syringes leads to lower administered activity than intended. Nuclear Medicine Communications, 22(5), 493–497. https://doi.org/10.1097/00006231-200105000-00005
Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., Schuff, K. G., Sherman, S. I., Sosa, J. A., Steward, D. L., Tuttle, R. M., & Wartofsky, L. (2016). 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 26(1), 1–133. https://doi.org/10.1089/thy.2015.0020
Hung, J. C. (1997). Radioiodine dispensing and usage in a centralized hospital nuclear pharmacy. Thyroid, 7(2), 289–294. https://doi.org/10.1089/thy.1997.7.289
Keskintepe, D., & Özer, A. Y. (2005). Residual radioactivity in the syringes used in injection of radiopharmaceuticals and factors affecting the amount of residual radioactivity. Fabad Journal of Pharmaceutical Sciences, 30(4), 176–180.
Kvaternik, H., Gatterer, J., Plhak, E., Schwarzgruber, J. F., & Aigner, R. M. (2020). Systematic Assessment of the Adsorption of 99mTc-Radiopharmaceuticals onto Plastic Syringes. Journal of Nuclear Medicine Technology, 48(2), 168–173. https://doi.org/10.2967/jnmt.119.235432
Ladrière, T., Aussage, L., & Vigne, J. (2024). Container-content interactions with radiopharmaceuticals: Seeing is believing. European Journal of Pharmaceutics and Biopharmaceutics, 196, 114200. https://doi.org/10.1016/j.ejpb.2024.114200
Ladriere, T., Desmonts, C., Zimmermann, P.-A., Peyronnet, D., Agostini, D., & Vigne, J. (2023). Impact of disposable syringes type choice on myocardial perfusion imaging procedures with [99mTc]Tc-tetrofosmin. Journal of Nuclear Cardiology, 30(4), 1399–1405. https://doi.org/10.1007/s12350-022-03143-w
Mushtaq, A., Ur Rehman, T., Safdar Mansur, M., & Jehangir, M. (2008). Adsorption of 99mTc-radiopharmaceuticals onto injection vials and syringes. Journal of Nuclear Medicine Technology, 36(2), 91–94. https://doi.org/10.2967/jnmt.107.048561
Nguyen, N. C., Anigati, E. M., Desai, N. B., & Öz, O. K. (2024). Radioactive iodine therapy in differentiated thyroid cancer: An update on dose recommendations and risk of secondary primary malignancies. Seminars in Nuclear Medicine, 54(4), 488–496. https://doi.org/10.1053/j.semnuclmed.2024.05.002
Saha, G. B. (2004). Fundamentals of Nuclear Pharmacy (5th ed.). Springer.
Stavrou, P. Z., Papachristou, M., Persakis, E., Kouvelis, K., & Datseris, I. E. (2016). Residual activities of 99mTc-labelled radiopharmaceuticals in routine nuclear medicine practice. Nuclear Medicine Communications, 37(6), 658–663. https://doi.org/10.1097/MNM.0000000000000487
Stopar, T. G., Socan, A., & Peitl, P. K. (2007). Adsorption of radiopharmaceuticals to syringes: Setting up a reliable protocol for its assessment. Nuclear Medicine Communications, 28(12), 951–955. https://doi.org/10.1097/MNM.0b013e3282f1b9b7
Swanson, T. N., Troung, D. T., Paulsen, A., Hruska, C. B., & O’Connor, M. K. (2013). Adsorption of 99mTc-sestamibi onto plastic syringes: Evaluation of factors affecting the degree of adsorption and their impact on clinical studies. Journal of Nuclear Medicine Technology, 41(4), 247–252. https://doi.org/10.2967/jnmt.113.132159
Wadsley, J., Armstrong, N., Bassett-Smith, V., Beasley, M., Chandler, R., Cluny, L., Craig, A. J., Farnell, K., Garcez, K., Garnham, N., Graham, K., Hallam, A., Hill, S., Hobrough, H., McKiddie, F., & Strachan, M. W. J. (2023). Patient preparation and radiation protection guidance for adult patients undergoing radioiodine treatment for thyroid cancer in the UK. Clinical Oncology, 35(1), 42–56. https://doi.org/10.1016/j.clon.2022.07.002
Willegaignon, J., Fernandes, S. C. P., Pelissoni, R. A., Coura-Filho, G. B., Sapienza, M. T., & Buchpiguel, C. A. (2023). Radiation safety measures in diagnostic nuclear medicine, based on the potential radiation dose emitted by radioactive patients. Radiologia Brasileira, 56(1), 13–20. https://doi.org/10.1590/0100-3984.2022.0064
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Anggoro Praja Mukti, Hilda Ismail , Teuku Nanda Saifullah Sulaiman
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under aCreative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
